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A. SUMMARY
The present proposaL deaLs with a new
programme (982 - 1986) of the EEC in
heaLth research, to be carried out by
sectora L research and deve Lopment
the f ieLd of medi caL and pubL'ic
means,cf the concerted action method.
I
{
It aims at increas'ing the effic'iency of the reLevant R & D efforts in the
Member States through the mobi Lization of the avai LabLe resear"ch potentiaL
of parts of nationaL pnogrammes and its graduaL coordination at Community
Leve L .
ParticuLar attention is devoted to the potentiaL economi c and industriaL
deveLopment within the fieLds covered by the research actions of th'is
programme, 'in conform'ity with Arti cLe 235 of the Treaty estabLish'ing the
European Econom'ic Commun'ity and in accordance v.rith the objectives and
means of action described in ArticLe 2 of the Treat'y.
This proposal constitutes a step towards the sectoral grouping of Communit;,
research actions in the fieLd of medicaL and pubLic heaLth research and
towards the rat'i onaLization of structures and procerjures for the "prepara-
tion, examination and impLementation of Community R & D programmes".
The programme proposaL, by presenting a coherent sclreme of Community con-
certed research, provides for the cont'inuation of the first medicaL research
programme (978 - 1981) and the integration of the second one (1980 - 1984)
as weLL as for new activities in cniticaL aneas of common'interest. It is
subdivided into three subprogrammes :
Subprog ramme 1
Subprogramme 2
Subprogramme 3
further deta i Led
HeaLth probLems
HeaLth resources
PersonaL envi ronment (diet and dr^ugs)
Each one is in research areas grouping severaL projects.
OveraLL programme impLementation wiLL be ensured by one "GeneraL Concerted
Action Committee" assisted in its tasks by four "Concerted Action Committees"
with defined scientific-technicaL competences, each responsibLe for the
optimaL execution of severaL projects entrusted to'it.
a
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The Member States intend,according to the ruLes and procedures appLicabLe
to their nationaL programmes, to carry out the research work estimated to
invoLve gLobaL financiaL contributions of about 300 miLlion ECU over the
programme period of 5 years (982 - 86).
The Commission is respons'ibLe for the coordination of the nationaL research
contnibutions to the pnogramme at Community LeveL. The appropliations ne-
cessary to finance the Commun'ity contribution to such coordination are
evaluated to be in the order of 2A miLlion ECU for the duration of the pro-
gramme. This figure incLudes staff expend'itures for a totaL of 10 officiaLs
(4 of them were aLready aLLocated to the 2nd medicaL research programme).
Interested non-Member States participating'in European Cooperation in the
fieLd of Scientific and TechnicaL Research (C0ST) wiLL be invited to asso-
c'iate whoLLy on partLy with this programme.
In order to ensure continuity, the programme is foreseen to start on
1 January 1982.
I
*
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B. INTRODUCTION
The CounciL Oecisions of 13 February 1978, adopting three concerted actions
as a first Community research programme in the fieLcl of medicaL and pubLic
heaLth research, gave a new dimension to the task of the Commission, nameLy
to extend its efforts of "graduaL Ly coordinating nationaL research acti:
vit'ies" to a further anea of incneasing'importance for the Community.
The first programme was foLLowed by the CounciL Decision of 18 March 1980(t \(8O/344/EEC'*'), adopt'ing a second medicaL research pnogramme consisting
of four muLtiannuaL concerted actions.
The Latter Decision was of cruciaL importance to the Commission since it
confirmed the option taken by the Counc'iL, and furthermore settLed the
institutionaL probLem of using under certain conditions the AnticLe 235
of the EEC Treaty for undertak'ing medicaL and pubLic heaLth research.
The foLLowing concerted actions are presentLy impLemented:
I
{
I Regi st ration of
CeL LuLar ageing
3. ExtracorporeaL oxygenation (3)
Detection of tendency to thrombosi s
Hea ri ng i mpai rment
PerinataL monitoring
7. Quantitative eLectrocardiooraohy
congenitaL abnormaL'ities (' 5)
(2) a?. 1 st programme(.1 
.1978 - s1 .12.1981)
( /.\\T/lnd p rog ramrne
(1 
.6.1980 - 31 .5.1984)
4.
A
(1) 0J
(2) 0J
(3) 0J
(4) 0J
(5) 0J
No L 52,
No L 52,
No L 52,
No L 78,
No L 43,
23.2.78, 9 - 20
23-2.78, p.24
23.2.78, p. 28
25.3.80, p. 24
14.2.81, p. 12
s
a'
v
-)-
The concerted action method for initiating Community activit'ies in the
medicaL and pubLic heaLth fieLd in a number of weLl defined topics has
been preferred at the time of their proposaL.
Two main reasons Led to this choice/ nameLy the existing dicrepancies
between nationaL research poLicies and strategies/ as stated at an earLier
conf rontat'ion exenc'ise (CREST/22l76), as weLL as the existence of many
scattered and reLativeLy smaLL nesearch teams at nationaI LeveL. The va-
lidity of this chojce has been pnoven and at present more than 400 nationaL
projects are coordinated by the ongoing seven EC actions. The number of
institutes wishing to join this venture is in f act steadi Ly 'increas'ing.
The cLose coLLaboration evolved over ten years between the Committee on
MedicaL and PubL'ic HeaLth Research CRM/CREST and the Commission has faci-
Litated considerabLy this coordination.
The achievements'in coordination and the recognized scient'ific and technical
enhancement of resutts of the actions of the first programme confirm the:
remankabLy improved effi ciency of national efforts in the respect'ive
fieLds,
favourabLe cost/benefit ratio of the Commun'ity funds spent for co-
ordi nat ion purposes, and
- strengthened confidence and interest of the Member States in this form
of Community action forits contribut'ion to economic returns in the bio-
medicaL and industriaL fieLds.
CRM, assisted by its SpeciaLized tJorking Groups, aLso advised the Commission
to promote a wide range of expLoratory activities in the form of stud'ies,
seminars, workshops etc. Thus, a coherent scheme has been set up, where
3 br"oad subprogrammes have been defined. Each of them is divided in research
areas where the ongoing concerted actions and a number of new projects ane
integrated.
Considering the above, the Commission advised by CRM prepared its present
proposal for a sectoral R & D programme of the EC in the fieLd of medicaL
and oubLi c heaLth research.
3
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This proposaL provides for the foLLowing specific requ'irements :
I
:l
continuation of the concerted actions
their extension and/or expansion, as
their proposaL (COM(77) 282 finaL);
integration of the concerted actions
thei r present state of evoLution and
(COM(78) 377 T'inaL);
of the fi rst programme enabIing
aLready foreseen at the time of
of the second programme
oLans for extension and
considering
continuation
- impLementation of new actions in criticaL fieLds of common interest;
- support of centraLized coord'ination faci Lities, whenever requ'ired.
The proposaL presents a coherent scheme of Community act'ions as shown in
tabLes I - Iii. It const'itutes a step towards the sectoraL grouping of
Community medicaL research actions of the Mernber States conducted unden
the EEC Treaty, and the rationaLization of structures and procedures for
the "preparat'ion, examination and impLementation of (lommunity R & D pro-
grammes" in conform'ity with the CounciL concLusions of 20 December 1979.
ReLevant activities in progness in other countries as weLL as those of
appropriate internat'ionaL onganizations such as lr'lH0, 0ECD, CounciL of
Europe, European MedicaL Research CounciLs of the Eunopean Science
Foundation, etc. r^lere taken into consideration when prepaning the project
proposaLs.
The concLusions of the meetings of the Ministers of PubLic HeaIth (13.12.197'7
and 1 6.11.1978) have aLso been considered.
In the impLementation of the pnesent pnogrammeo cLose coor"dination is en-
visaged withother research prognammes of the EC which incLurde or are reLatecl
to medicaL and/or pubLic heaLth research components. At present these incLude
t
- parts of the research
materiaLs and methods
to t he product'ion of
interest;
programme of the EC in the field of reference
(Community Bureau of Reference) (1 ) neLated
standards for materiaLs which are of biomedicaI
(1) 0J No L 258, 13.10.79, p. 32
]l
a
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- the sectoraL R & D programme of the EEC in the field of envi.ont"nt(2),
in particuLar for the part reLating to man-environment interact'ion;
- the p[an of action of the EEC in the fieLd of scientific and technicaL
information and documentation (3) for its part concenning "B'iomedicaL
Informat ion";
- the research and train'ing programme of the EAEC in the fieLd of bioLogy -
heaLth protection (Radiation Pnotection Programme) (4) in its medicaL
and pubLic health aspects;
- the current four. ECSC research programmes 
(5-8) 
reLated to occupationaL
heaLth;
- the action programme of the European Communities on safety and heaLth
, (9)at hlorK
- 
Finally, iruporbant areas of this proposal, nanel"y areas I.I.
(Pre-, peri-, and postnatal care) and I.2' (Egeing, Disablecl
anil Hanil1capped) can be seen in the perspective of the
International Year of Disabl-ed Persons and of the opinions
of the European Parliarnent and. the Economj.c and social connittee
pertaining to it.
(D 0J I'lo L 101 , 11 .4.81 , P. 1
(3) 0J No L 311 , 4.11 .78, P. 1
(4) OJ No | 78, 25.3.80 
' 
P.19
(5) 0J No c 10, 14.1 .77, P. 2
(6) 0J No C 159 , 5.7.78, P. 2
Q) 0J No C 161 , 1.7.80, P. 4
(8) 0J No C
(9) 0J No C 165,11 .7.78, P. 1
a
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JUSTIFICATION AND ORIENTATION$
The diseases of modern society with their incidence on industrial deve-
Lopment and the steadiLy mounting costs of hea[th care are among the most
important economi c probLems confronting aL L Member States.
Nationat efforts to solve them are in progress. Thus, t^/ithin the Community,
there exists a considerabLe potentiaL for" scientific research and in-
dustriaL deveLopment. If mobiLized within the fname of a coherent Commu-
nity medical research programme it wouLd aLLow the reaLization of evident
scientific pl'ogress, giv'ing adequate and more effective information.
t. 9!ies!:ye:
The main objectives of European cooperation in the sector of medicaL
and pubti c heaLth research are prevention, earLy detection of d'isease
and rehabi Litation. Mone specificaL Ly they aim at the foLlowing,
nameLy to:
a) optimize the capacity and economi c effi ciency of heaLth care
efforts by initiating or impLementing common actions in defined
fiel.ds considered as cniticalLy reIevant to the sotution of major
heaLth probLems and thei r incidence on occupationaL heaLth;
b)'improve efficiency of ongoing nationaL R & D through the encoura-
gement of concerted actions thus making a better" use of the avai-
LabLe research potent'iaL;
c) promote through coordinated efforts an active interaction of the
Nationa! Research Agencies, of the HeaLth Authorities and of the
Biomedi caL Industries, Leading to an acceLerated raisinq of the
sociaL and economi c weLf are of the Commun.ity;
d) graduaL Ly coordinate, at community LeveL, the nationaL research
programmes 'in the fieLds of common intenest. The implementation
of the research work is the remit of competent researcn or"qani-
zations of the Member States;
t
{
l
t
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e) provide a systematic tempLate for medicaL and pubLic heaLth research
in the Community R & D poLicy by bringing under" it an 'increas'ing
proportion of nationaL reseanch aciivities in th'is sector.
z. !.gs!i!res!ren
The Legat basis for this programme is ArticLe 235 of the Treaty esta-
b L i shi ng the European Economi c Commun'i ty and t he Counci L Deci si on of
18 March 1980 .fi}/344/cEE (1) ) adopting the second medicaL research
programme.
0n this bas'is, and in L'ine wjth the concLusions of the 619th meeting
of the CounciL on 20 December 1979 (doc. 4230/80/RECH.1), the
Commission prepared the present proposaL for a ne\,', "sectoraL" R & D
programme in which an attempt is made to gnoup severaL ongoing and
net^r research actions pertain'ing to the fieLd of medical and pubLic
heaLth research.
Although this research fieLd'is not mentioned among the areas of fore-
most prior"ity, the Commission proposes to devote to it a certain pro-
portion of its R & D efforts, in conformity with the CounciL concLusion
"not to excLude a priori other areas where a Community contribution
couLd be of particuLar value for the Comrnunity" (see : COM(80) 412
f inaL).
Simi LarLy, this programme proposaL corresponds to the Resolution of the
European ParLiament embody'ing its opinion on both earLier programmes,
in which "the Commission is expected, in accordance with the tradi-
t'ionaL Ly un'ivensaL nature of medi caL knowledge, to continue to promote
such research at Eunooean LeveL and to ensure that it is coordinated
and, where possibLe, 'integrated with simi Lan research being carried out
in other parts of the world".
Moreover, the Council Decision of 9 April 1981 (2) on the concLusion
of the Agreement between the EEC and the Swiss Confederation on a con-
certed action, shouLd be considered as a beginn'ing of assoc'iating non
Member States, participating'in COST, whoLty or partLy w'ith this pro-
o ramme.
t
(1)
(?>
J0NoL
JONoL
78, 25.3.80,
113, 25.4.81 ,
p. ?4
p. 44'|}
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3. grlsrlslre!:
Current nat'ionaL pnogrammes in the fieLd of medical and pubLic heaLth
research are predominantLy oriented to disease-reLated targets such
as : cardiovascuLar disorders, mentat i L Lnesses/ congenitaL abnorma-
Lit'ies, geriatric diseases, etc. Here, progress de'rives lar"geLy from
individuaL efforts and disseminat'ion of information'is assured by
scientifi c societies. Develooment as t^reL L as coordination at nationaI
LeveL is ma'inLy or" partiaLly done by making avaiLahrLe purpose-Linked
oubLic research funds, The Commiss'ion, 'in Line with the advise of CRM
does not feeL that additional coordinat'ion efforts aLong these targets
ane considered opportune or necessar), at Community LeveL.
In compLiance with 'its mandate and orr advi ce of the CRM, the Comm'ission
proposes to orient its sectoraL R & D programme towards more compre-
hensive targets of common interest.
The pnesent R & D programme proposaL wi LL at^Low for more effective re-
search through coL Laboration and coordinat'ion at EC LeveL making use
of a muLtidiscipl'inary research potentiaL beyond the possibi L'ities of
any singLe country. It focuses on the foLLowing three key areas, herein-
after referred to as subprogrammes, reLating to :
Hea Lt h Pr"ob Lems
HeaLth Resounces
PersonaL environment (Diet and Drugs).
The first R & D subprogramme- is essentialLy oriented to the soLution of
those heaLth probLems'invoLving the criticaL phase,s of human Life, namely
b'irth and oLd age, to the effects of the Life-styLe nelated stress of the
industriaL envi ronment and the abi lity to cope with it, and to the 'irnpro-
vement of rehabiLitation of the disabLed and handicaoped.
It wouLd thus promote the identif icat'ion of ways and means LikeLy to
maximize the resuIts of scientifi c and technoLogicaL progress, and
to minimize the negative economi c and soc iaL consequences related to
'inappropriate intervention in these aneas.
.a
{
I
)
?
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The second R & D subprognamme is oriented to the improvement and appro-
oriate use of those heaLth resources required to ensune optimizat'ion of
the cost-effectiveness ratio in the heaLth care fieLd. ParticuLar atten-
tion is given to coordination of efforts to deveLop heaLth services re-
search, improve heaLth technoLogy and promote upgrading and quaLifica-
tion of human resources.
The th'ird
standi ng
di et and
nonment.
R & D subprogramme focuses on the need for a betten under-
of the effects on the individuaLrs heaLth resuLting fnom its
the intake of pharmaceuti caLs, as part of its personaL envi-
a
a
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D. PROGRAMME CONTENT
HEALTH PROBLEMS
This subprogramme covers research aimed at estabLishing the b'ioLogicaL,
phys'ioLogi caL, technoLog'i ca L, epi demi oLogi caL and organi zat ionaL data
required for improving the medicaL intervention at birth, during deveLop-
ment and in oLd age, as weLL as the effective prevention, betten handL'ing
and reduced dependence of unfitness, be'it the consequence of congenitaL
or acqui red handi caps. ResuLts from these invest igations are expected to
have an important faL L-out for the European biomedi caL and phanmaceuti caL
industries.
The subprogramme aLsro incLudes studies on the quantification of risk po-
tentiaL and adapt'ive responses to psychologicaL and sociaL stresses, of
particuLalimportance to the area of occupationaL heaLth.
Pant of the research incLuded in this subprogramme is aLready coordinated
in ongoing "concerted Actions" of the 1st and 2nd medicaL and oubLic
heaLth research prognammes. It is proposed to continue these actions.
Arce--L l!g:.-sslt:e-9!d-p99!-!q!g!-9 gt g
TechnoLogicaL deveLopment and assessment for perinataL monitoring pro-
cedures with emphasis on non-invasive techniques. ParticuLan attention
wiLL be given to thein reLiabiLity, to the reLevance of information ob-
tained, to nnother distress and risks, as lleLL as to foetaL Loss.
Research in Laboratories equipped to carry out chr"oup{me anaLysi s wi L L
endeavour to soLve techni caL probLems needed to reach partial Ly automated
measunements. SimuLtaneous paraLLeL biochemicaL and qeneticaL studies
are envi saqed.
- The determination of inborn metaboLic errors through a uniform methodic
approach to different screening programmes aims at rjefining the critelia
for monitoring their incidence and prevaLence in the Member States, at
diagnos'is and at deveLopment of treatment.
a
{
I.
I
Particulan attention wiLL be g'iven to treatable errors, and
wi LL incLude studies on cyst'ic f ibrosis, hemogLobinopathies
L'ipoproteinemia.
the
and
nnni arf
t/, vJ!vL
nype r-
t
)
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The congenitaL anomaLies registry in progress wi LL be complemented by
invest'igations on intrauterine diagnos'is and studies on earLy foetaL
Loss, death in earLy chi Ldhood and foetal growth disturbances.
- Current practices in Member States regarding car"e deLiveny:.nl3ll5;-, and
in panticuLar the appLication of technicaL devices and procedunes to
perinataL medi c'ine, incLuding cost/effectiveness evaLuat ionsrwi L L be
exami ned.
Area 2 z 4gstng.-dt:e!!sq-sld-!qldr gsppsg
t
The continuat'ion and further deveLopment of the concerted action on
ceL LuLar ageing w'i L L invoLve studies at organ, ceL LuLar and sub-ceL LuLar
LeveL. It is pt'oposed to incLude aLso further investigations of the 'im-
mune response during ageing incLuding stud'ies contributing to the under-
standing of arthritic diseases, and of ageing of the brain and seniLe
dementia. The problem of premature, as opposed to normaL, ageing wiLL
be consi dered.
Ageing of the Lens and hearing'impairment form the crux of the action
on sensoriaL impairment partLy covered by ongoing concerted act'ions.
The deveLopment of adequate aids to vision and hearing deterioration or
Loss due to a metaboLic or occupat'ionaL origin wiLL be considered.
B'iomateriaL compatibi Lity studies, cLosely associated with technoLogicaL
deveLopments, wi L L form the basis of this neseanch.
The continuation and deveLooment of the concerted action on detection of
i t i es a re expected tothrombosis and pnevention of its resuLting disabiL
Lead to a better understanding of the pathogenesis of thrombosis as weLL
as to the ava'iLab'il'ity of adequate tests wh'ich wj L L aid in the prevent'ion,
earLy d'iagnosis and treatment of the disease.
EvaLuation and identification of
bLed wiLL be undertaken to define
caL deveLopments.
spec'ific needs as regards aids for" disa-
coordinated activities Leadinq to techn'i-
The pattern of care for the chroni c
funct'ional d'isabi Lities, and for the
in a study on care deLivery systems.
be taken into account.
or Long tenm patient with severaL
'impa'ired eLder Ly wi L L be exami ned
ReLevant epidemioLogicaL aspects wi Ll
a
- 
1t. 
-
grceBdeun-in-edep!q!len
a
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The determjnation of measurabLe parameters which cou{.d indicate first
a posten'ioni but aLso a priori the tendency olinitiation of breakdown
'in adaptation or the form it may take jf no counter-measure is intnoduced,
forms th'is compLeX muLtidiscipLinary pnogramme. It is envisaged to
deveLoped it into paraLleL projects strictly coordinated between them-
,seLves. Particular attention wiLI be given to high lisk groups in the
worki ng popu L at i on 
"
Studies on quantification of parameters aim at the simultaneous evaLuation
of aIready measurabLe hormonaL parameters as well as psychologicaL and
socioLogicaL ones.'fhe improvement and standandization of methods for mea-
suling possibLe bioLogicaL markers of the adaptive process ane oart of
these studies. The interaction of various discipLines cLoseLy associated
with studies in the foLLowing projects form the basis of the whoLe
area"
Coord'ination of the ongoing uncorneLated efforts in severaL Member States
to invest'igate the performance decrement of workens under various envi-
ronmentaL cond'itions so as to avoid accident proneness is envisaged,
using the multidiscipI inary approach mentioned above.
App['ication of the same muLtidisciplinary approach t,c the fieLd of cardio-
vascuLar diseases with par"ti cuLar reference to hypertension and ischaemi c
heart d'iseases is here envisaged. Studies wiLL be integrated with resuLts
from other" projects and invoLve the evaluation of psychosociaL and neuro-
endocrine factors'in seLected groups of subcLinicaL,and cLinicaLLy esta-
bLished patients combined with appropriate monitoring of the reLevanr
physioLog'i caL variabLes.
The modeL indicated above wi LL be appLied to correLa te gast ro-intest ina L
and psvchosociaL measure-
inaL compLaints and esta-
d'iseases uvith the resuLts of psychobiotogi caL
ments. Subjects with borderLine gastro-intest
bLished cases wi LL be studied.
A further particuLar study of increas'ing importance for heaLth and safety
at work is env'isaged in order to assess the reLevant probLems of drug abuse.
Effects of aLcohoL abuse as h/eLL as the mechanisms invoLved in the oroneness
to it, of tobacco or products associated with its consumption, as weLL as of
potentiaL op'iate intake on the centraL nervous system and the generaL meta-
boLism, wilL be examined in bioLogicaL and ep'idemioLogicaL studies.
'l.
J
II
)
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HEALTH RESOURCES
This subprogramme comprises 3 main areas of research : the 1st one aims at
assessing health services research concerned w'ith the deveLopment of heaLth
services particuLarLy in reLat'ion to changes in soc'iaL, demographic, envi-
ronmentaL and occupationaL conditions. Correct and probLem-oriented deveLopment
of health technoLogies incLuding the transfer of new knowLedge andmethods from
basic hard and soft sc'iences into medicaL technoLogies, as t^reLL as the assess-
ment and testing of medicaL equipment form the 2nd area in this subprogramme.
Important impacts on the European biomed'i cal industries can be foreseen.
The 3rd area deaLs with quaLitative improvement of medicaL resea,r"ch scientists
in fieLds in which knowLedge and technoLogy ar"e progressing rapidLy and where
highly skiLLed researchers are criticaLLy needed-
Arsc--1 : lce!!!-99rvts99-lseeelg!
HeaLth services t'esearch has to deveLop generaLLy acceptabLe scientific methods
to investigate efficiency of different heaLth systems, effectiveness of various
medicaL pnocedunes and technoLogies, and to analyse probLems of planning/ orga-
nization, management/, evaLuat'ion and acceptabi lity of heaLth serv'ices in their
reIationship to sociaL and env'i ronmentaL ci rcumstances, in order to ensure opt'i -
maL heaLth of the working popuLation in a cost-efficient way.
Variations in organization and structure of heaLth services research in the
Member States as 1^leLL as speciaL research requ'irements and difficuLt'ies entaiL
a st'i Ll poon deveLopment of research in this area-
The pnoposed research therefore aims, in a first phase, at the deveLopment on
Community scaLe of a common methodoLogy incLud'ing strateg'ies for comparative
evaLuation studies which invoLve evaLuation of process (effic'iency) and assess-
ment of outcomes versus the originaLly stated object'ives (ef fect'iveness).
In a second phase, four interreLated topics ane seLected for eLaboration:
- Coordination of heaLth serv'ices research : foLLow'ing evaLuation of the
present state of the art of heaLth services research in the Member States,
of its probLems and of its organ'isation and structune, this topic wiLL aim
at the coordination of ongoing nationaL efforts in order" to deveLop at
Community LeveL an efficient research in this area-
- Assessment of heaLth status : the deveLopment of heaLth indicatons is a
basic tooL in occupationaL heaLth, in determin'ing the need for earLy care
in specific popuLation gnoups and in identifying risk factors.
tj
t
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Research on pnevention : the change in emphas'is fronr medicat'ion to heaLth ' {
promotion has incneased the demand for further knowLedge about heaLth, risk
factors, infLuence of the working environment on heaLth, as weLL as the use ,
of medicaL services, sick Leave, accidents at tntork and dnug consumption;
reLevant nat'ionaL activit'ies wi L L be assessed in order to eLaborate a con-
certed approach.
Community versus hospitaL care : this research top'ic aims at assessing the
feasibiLity and potentiaL importance of community cane to the popuLation in
'its home and occupational environment, 'in comparison with hospitaLization
and by considering'in particuLar technoLogicaL pr"ogress in mon'itoring and
drug deL'ivery, as wel.L as deveLopment of new drugs.
Area !cc!!!-Igs!lg!egv
A continuat'ion and deveLopment of the ongoing concerted action on extracor-
poreaL oxygenation wi L L consider advanced technoLogi caL deveLopments for
the repLacement of body functions. DeveLopments foresee further research on
oxygenator design and perfonmance as weLL as paraLLeL studies'into aLterna-
tive methods of oxygenation incLuding enzyme binding to membrane and re-
search on biomateriaLs.
The concerted action on common standards in eLectrocar"diography wiLL be con-
tinued in a broader context of quantitative functionaL assessment to incLude
the standardizat'ion and'improvement of diagnostic criteria. The same approacfr
wi LL be used for computerized anaLysis of other d'iagnostic f unct'ionaL para-
meters.
The monitoring of deveLopments in the fieLd of imaging techniques, both
in vivo and in vitro'is of great intenest and wiLL be carried out in a spe-
cific project. P'iLot studies to define common muLtipurpose packages for
image eLaboration may be'initiated.
Criteria for better expLoitation of the possibi Lity of ambuLatory monitoring
of physioLog'icaL variabLes of great diagnost'ic importiance wi LL be def ined.
Its appLication to rehabi Litation, therapeutic needs, dnug use and occupa-
tionaL heaLth wiLL be examined.
- The deveLooment of cLinicaL and technicaL evaLuation clf new med'icaL devices
and pnocedures,incLuding cost/effjcieney aspects is the scope of this act'ion.
It wiLL incLude a comparative evaLuat'ion of medicaL equipment'in technical
and user trials undertaken by a paneL of cLinicians, scientists from the par-'
ticipating centers in Liaison with heaLth authorities"
C.
]
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A rea Human Resources
This area shaLL deaL with methodoLogicaL research on ways and means for pro-
viding industny as weLL as pubLic and private inst'itutes with highLy quaLified
research scientists in need-areas such as toxi coLogy, occupationaL heaLth,
advanced heaIth technoLogy, clinicaL jnvestigat'ion, heaLth services management
and ep'idemioLogy.
The projects aim first at the evaLuation of present and future needs, confron-
tat'ion of nationaL measures taken, identification of sui tabLe upgrading faci-
Lities, and subsequentLy at the development of coordinated procedures. Assess-
ment of the'ir efficiency through test cases in toxicoLogy, advanced heaLth
technoLogy and cLini caL invest'igation is envisaged.
III PERSONAL ENVIRONMENT (Diet and Druqs)
A nutritionaL research programme wiLL aim at ascerta'ining the diet component
invoLved in the occurrence of diseases such as arteriaL hypertension and di-
gestive tract diseases. It incorporates deveLopment and impLementation of
specific methodoLogies for the study of food and the detection of individuaL
pred'isposition to the relevant diseases. Research based on muLti center studies
wiLl aim at assessing by post-marketing cLinicaL triaLs of adequate scale the
efficacy of specific drugs as weLL as at deveLoping a drug surveiLLance project.
A rea Ng!r:!ren
The importance of dietary factors in the promot'ion of hypertension wiLL be
investigated to identify adequate measures of prevent'ing their effects.
Th'is project includes bioLogicaL and epidem'ioLogicaL aspects so as to de-
fine the prevaLence in each Member State and the env'ironmentaL causes of
the disease. These studies wiLL have a relevant impact on the European
food industry at production and marketing LeveL.
Area 7 Pharmaceuti caLs
Adequate post-marketing drug surveiLLance and muLticenter controLled cLinical
triaLs requir'e studies on very Large popuLations for the short- and Long-time
evaLuation of both new and oLd pharmaceuticaLs.Ongoing activities in the
Member States are scattered, unreLated to each other and therefore of tninor
effectiveness. By regrouping and coordination, thus by making better and morerf
- It 'is proposed to st
to test the effi cacy
contnoLLed triaLs of
and di ssemination o'f
of old and new drugs
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effect'ive use of existing and potentiaL resour"ces, joint medicaL research con-
ducted at Community LeveL wouLd give a greater and more consistent support
to the pharmaceuticaL'industry, contnibute to drug deveLopment, and ensure a
qui cker warning systern.
imuLate and coordinate post-marketing cLinicaL triaLs
or some specif ic effects of pharmaceuticaLs. Such
adequate scaLe airn at appropriate coL Lection, storage
information on new deveLopments and on the efficacy
In orden to improve exist'ing mechanism:; for identifying adverse effects
of drugs which because of Low incidence on Late occurrence have escaped
premarket'ing test'ingr'it is proposed to deveLop a post-marketing Crug
surveilLance croject, It wouLd promote exchange and earLy dissemination
of informat'ion and wouLd attempt to suppLement existing methods by dif-
ferent appt.caches i.e. case controL sur"veiLLance and record Linkage drug
survei L lance.
{
lD
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E. PROGRAMME IMPLEMENTATION
The basis for optimaL impLementation of the proposed R & D programme is
the sharing of its inhenent responsibiL'ities between the Member States
and t he Comm'i s s'i on :
- The Member States endeavour to carry outra.ccofding to the rutes andpnoce-
cedures appLicabLe to their nationaL programmes, the execution of the
research as described in the foregoing chapter D, and are prepared to
integrate such resear"ch into a process of coordination at Community
LeveL over the Programme Period'
- The commission is responsibLe fon such coordinat'ion of the
tributions to the programme as weLL as for" the management
budget aLLocated to it (see chapter G) '
An act'ive Parti c'iPation of
mandatory e.g. in the case
cuLar research Line.
FoL Lowing the Counci L Deci sion, thi
operation in the fieLd of Sc'ientifi
be invited to ParticiPate to aLL or
A reexamination of the Prognamme
whi ch may Lead to a revision 'in t
in the prepanation of a ProPosaL
to constitute a foLLow-uP to the
nationaL con-
of the CommunitY
aLL Member States in each single project is not
of absence of a nat ionaL programme in a part'i-
rd countries i nvoLved in European co-
c and Techni caL Research (C0ST) wi L L
oarts of this Programme-
ImoLementation is carlied out as a concerted action programme reLating to
r,leLL defined research fieLds chosen for European coLLaboration, and'in-
cLudinq the act'ions of the 1st and Znd medicaL programme'
t
The nat.ionaL contributions to this programme and thei r coordinat'ion at na-
t.ionaL LeveL, as weLL as the seLection of nationaL experts for thein sc'ien-
t.if.icmanagement,w.iLLbepartoftheresponsibiLitiesoftheconcerned
authoilit'ies in the Member states. These authorities are indi cated in
Append'ix 3 of the proposed Counc'iL Dec'ision'
is foreseen at the end of the third year
he counse of the fourth year as weLL as
for a poss'ibLe new pnogramme intended
oresent one.
,
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F. OPERATIONAL AND MANAGEMENT STRUCTURE
An adequate operational and management structune is indispensabLe in onder
to:
- ensure maximum efficacy in both programme impLementation and coordination,,
- meet the requests stressed by the CounciL in its ResoLution of 1974 and
its ConcLusions of 1979,
- achieve the objectives of this prognamme (given in chapter C.1.),
- maximize economy and profits of the aLLocated budget whiLe ensuring aLL
the spec'ific requests to achieve the research goaLs of the programme
(see page 6).
The rat'ionaLization of structures and the simpLifi cation of procedures
aimed at in the present attempt of group'ing R & D actions in the sector
of medicaL and pubLic heaLth research, shouLd aLso aLLow a greater fLexi-
bi L'ity 'in prog ramme irmp L ementat ion and management .
1- 9psre!1g!s!-gltegllrs
Three subprogrammes are forming the overaLL R & D prognamme; their ope-
rationaL structure is shown in the foLLowing TabLes I - III.
Each subprogramme is divided into 3 research areas which group scienti-
fi caL Ly reLated projects.
Some pnojects w'iL L of course have to go thr"ough an organizationaL pre-
paratory phase before active coordination can start.
The foLLowing steps wiLL have to be taken for each project:
- the setting up of its own operationaL structure incLuding a technicaL
steering commi ttee,
- the identification of the contributing nationaL institutes,
- the appo'intment of a proj ect Leader, and
- the concLusions of contracts making avaiLabLe the funds needed for
coordinat'ion purposes.
I
G
SUBPROGRAMME
A rea T1 Pne-, peri-, and postnatal care
' tl
HE-ALIH-PBQBLEUq
PerinataL Monitoring
Chromosome AnaLysi s
Inborn MetaboLic Ernors
Congen'itaL AnomaLies
Care DeLivery Systems
Quantifi cation of Parametens
Performance Decnement
CardiovascuLar Diseases
Gastro-intestinaL Diseases
Drug Abuse
TABLEj
;
Proj ect
A rea r.2 Ageing, DisabLed and HandicaPPed
r11
I - | -t.
11?
r.1 .4.
14(
a Proj ect
Area I.3 Breakdown in Adaptation
I.2.1. CeLLular Age'ing and Diseases
I.2.2. SensoriaL ImPairment
I .2 .3. Thrombos'i s and D'i sabi L i t i es
1.2.4. Aids to the DisabLed
I .? .5. Ca ne De L i verY SYst ems
Pro j ect I.3.1 .
r.3.2.
r.3.3.
r.3.4.
T?q
Research A reas
t
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TABLE I I
suBflrgGSAMME II , !EALI!=EE99!B!E!
Research Areas and Proj ects
Area II.1 . HeaLth Servi ces Research
Project II.1 .1 . Coordination of HeaLth Servi ces Research
II.1 .2. HeaLth Status Assessment
LI.1 .3. Research on Prevention
II .1 .4. Communi ty vs . Hosp i ta L Ca r"e
Area II.2. HeaLth Tec!!oLogy
Project II.2.1 . RepLacement of Body Functions
and Biomaterial Research
II.2.2. Quantitative Functionat Assessment
I7.2.3. Imaging Techniques
II.2.4. AmbuLatory Monitoring
II.2.5. CLinicaL and Technical EvaIuation
Area II.3. Human Resources
Project I1.3.1. Upgrad'in_q 'in ToxicoLogy
II.3.2. " " Hea[th Service Management
II.3.3. " " Occuoat'ionaLHeaLth
Ii.3.4. " " Advanced Technology
II.3.5. , rr EpidemioLogy
II.3.6. " " Clin'icaL Investiqation
{
C
a
3
r
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SUBPR0GRAMME III : gEEggryA!=ENyIEgNgElI
(Diet and Drugs)
Research Areas and Proj ects
Area III.1 . Nutrition
Project IiI.1 -1 - Dietr Hypertension and
Digest'ive Tract Diseases
Area III.2. Pharmaceuti caLs
Project III.2.1 . CLin'icaL TriaLs
II1.2.2. Drug SurveiLLance
TABLE I ] I
a
a
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2. Uslegeqg!!-!,!re9!etg
0n the basis of the experience gained from the ongoing concerted actions
and foLLowing a critical exam'ination of the most rationaL management
structure for the optimaL'impLementation of this muLtidiscipLinary R & D
programme, the Commission, in agreement with CRM/ proposes the setting
uo of the foLLowino Committees :
a) 0ne "GeneraL Concerted Action Committee"rhereinafter referred to as
the "GeneraL Comm'ittee"/ ensures the best poss'ible impLementation of
the overaLL programme. For this purpose it is composed of representa-
tives of the Member States responsibLe for science and technoLogy in
the fieLd of medicaL and oublic heaLth research.
At nationaL LeveL, its representatives take care of the integrat'ion
of those parts of the'ir research activit'ies, which correspond with
thi s programme, into a process of coordination at Community LeveL,
whi Le the Commission ensures the coord'ination of the nationaL contri-
butions to the programme.
The GeneraL Committee
- advices the Commission on the aLLocation of Community funds needed
for" : coordinating purposes, supporting centraI ized faci lities,
meeting urgent needs in criticaL areas, and undertaking expLoratory
activities in view of the preparation of future pnogrammes;
coordinates within the programme the activation, dunati.on and poss'ibLy
earLy termination of the projects forming the nesearch areas of this
programme, on adv'ise of the respective COilACrs (see under b) assisting
it in its scientific-technicaL management tasks, and according to
emerg'ing needs on resuLts of periodicaL evaluations;
- indicates guideLines to the COMAC's.
b) Four "Concerted Action Committees", hereinafter refenred to as "C0MAC's"
{
I
C
ensure the scientific-techni
to each C0MAC, in conform'ity
GeneraL Commi ttee.
caL management of those projects entrusted
with its respective competence, by the
a
)
,
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For this function, each COMAC is oriented towards one of the folLow'ing
research domains:
1 . Epidemi oLogy, statistics and cl in'icaI t riaLs.
2. B'ioengineering, technoLogy evaLuation, t nansfer and standan-
dization.
3. AppLied bioLogy, physioLogy and biochemistry.
4. HeaLth services nesearch.
Its members wiLL be chosen among nationaL expents'in such a way that
aLL appropriate competences needed are made avai LabLe by compLementing
one another"; they wiLL be appointed by their r.esponsibLe nationaL
authorities.
Each COMAC, in parti cuLar :
- evaLuates the resutts of the projects entrusted to it, draws concLu-
sions as regards the'in appLication and reports its opin'ions and re-
commendat ions to t he Genena L Commi ttee;
- keeps abreast of ongoing reLevant research and techni caL deveLopment
LikeLy to affect the execution of the projects;
- suggests guideLines to the project Leaders.
o
,
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G. I^'AYS AND MEANS
1. Research funding
The financiaL voLume of the nationaL research contributions to this
research and deveLopment programme is estimated at 300 miLLion ECU
over the programme pen'iod, whi ch corresponds to about 1?% of the
aggregate funding of med'icaL and pubLic health research in the Member
. 
(*)
5r aI es
2. Coordi nat i on costs
The cost of coor"dination, charged to the Commurr'ity budget, is estima-
ted at 20 mi L L'ion ECU for" the duration of the pnoqramme.
These costs incLude administrative and technicaL expenditures, and ex-
penditure for staf f subd'ivided as f ol Lows :
a) Administration 1.40 miLLion ECU
b) TechnicaL (contracts) 15.30 tt tl
c) Staff 3.30 ', rl
__=11=11= 
'
a) Administrative expenditures are used mainly for organizing the meetings
of the 5 Concerted Action Commi ttees, as hJe L l. as f or convocation of
experts, FubLication, rniss'i ons, etc.
b) Techni cal expend'itures are spent :
- for contnacts w'ith project Ieaders in order to ensure scientific
coordination (organ'ization of meetings of techni caL steering
committee and of workshops, exchange of'personneL, dissemination
of informationo administrative heLp, etc.),
I
t
('t) Doc. CREST No 1245 /79
a
j
,
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for support needed by centraLized faci L'ities, whenever its proper
functioning requi res substantiaL and/or addit'ionaL funding, such
as : need of computer incLuding programmingrproduction and exchange
of costly material, breeding or maintenance of certain animaIs,
data evaluation of cLinicaL triaLs, pnepanation of reference soft-
ware, et c.
for support of nationaI experts in order to perform expLoratory
act'ivities by means of studies, workshops or seminars needed
either to compLement ongo'ing actions or to prepare netnl ones.
- for support of nationaI or private institutes in orden to make
poss'ibLe a rapid intervent'ion in the case of an unexpected but
urgent need of recognized importance,
Their distributions among the subprogrammes are as foLLows :
Subprog ramme 41 -49y"
36-44%
13-17%
tl II
III*
c) Staff expenditurel
Staff requested for
Community leve[ 'is
At present, 4 offtc
research programme.
executing the coordination of
10 officiaLs, i.e. 6 add'itionaL
t he p rog rarnme at
st af f .
iats Q A and 2 C) are aLLocated to the 2nd Medical
The 6 add'it'ionaL staf f (3 A, 1 B and 2 C) are nequested in vi ew of
the competence necessary to cope with the new research areas pro-
posed, to ensure the secnetariats of the GeneraL Committee and its
four COMACrs, and to carny out the coordination tasks.
iD
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ANI'IEX I
ProposaL for a Counci L Decision
adopting a sectoraL research and deveLopment programme of the European
Economic Community'in the fieLd of medicaL and pubLic heaLth research
- concented action -
(982 
- 1986)
THE COUNCIT OF THE EUROPEAN COMMUNIT]ES,
Having regand to the Treaty estabLishing the European Econom'ic Community,
and in panti cuLar Arti cLe 235 theneof,
Having regard to the proposaL from the Comm'ission,
Having r"egard to the opinion of the European ParLiament,
Having regard to the opinion of the Economic and SociaL Comm'ittee,
hlheneaspursuant to ArticLe 2 of the Treaty, the Community has been assigned
the task of promoting throughout the Community a hanmonious deveLopment of
economj c activities/ a continuous and baLanced expansion and an acceLerated
ra'ising of the standand of Living;
Whereas by Decision 7B/167/EEc,(1)r, urunded by Decision 81 /21/EEC (2),
and Decisions 78/168/EEC(3) and 7B/469/EEc(4), ahe Counci I has adopted three
concerted projects as a first research programme in the field of medicaL and
pub L i c hea Lth resea rch;
trlhereas by Decision 80/344/EEC (5) the CounciL has adopted a second research
programme in the fieLd of medicaL and public heaLth research, consisting of
four muLt iannuaL concerted proj ects;
(1) 0J No L 52, ?3.2.1978, p. 20.
(2) 0J No L 43, 13.2.1981 , p. 12.(3) 0J No L 52, 23-2.1978, p. ?4.
(4) 0J No L 52, 23.2.1978, p. 28.
(5) 0J No L 78, ?5.3.1980, p. 24.
i
i
{
e
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hlhereas 'in i ts resoLution of 14 Janua ry 1974 on an i nitiaL outLine programme
of the European Communities in the fieLd of science and technotogy (6) the
Counc'iL stressed that an appnopniate appnoach shouLd be adopted towards the
whole range of avai LabLe ways and means, incLuding concerted action z and
that whenever it proves necessary or desirabLe that non-Member States, par-
ticuLarLy European ones, shouLd be assoc'iated in these projects, steps shouLd
be taken to make th'is possibLe;
|lhereas, in its resoLution of 14 January 1974 (7) reLating in particuLar to
the coord'ination of nationaL poL'icies in the fieLd of sc'ience and technoLogy,
the CounciL entrusted the Community institut'ions with the task of graduaLLy
ensuring such coordination, aided by the Sc'ientific and TechnicaL Research
Commi ttee ( CREST);
t,rlhereas the sectoral R & D programme dealt w'ith by this Decision appeans ne-
cessary to attain in the course of the operation of the common market the
objectives of the Community as regards the harmonious development of economic
act'ivi t'ies, a continuous and baLanced expansion and an acceIerated raising
of the standard of L'iving, account being taken in particuLar of potentiaL
economic and industriaL deveLopment within the fieLds covered by the research
a reas;
tJhereas the Treaty does not prov'ided the specific powers of action required
for these ends;
lilhereas the Memben States intend, in accordance with the ruLes and procedures appL'i-
cabLe to their nationaL programmes, to carry out the research indicated in
Annex 1 o and are prepared to 'integrate such research into a process of co-
ordination at Community LeveL unti L 31 December 1986;
Wheneas the cost of such research, as indicated in the aforesaid Annex 1, per-
formed in the Member States is evaLuated at about 300 miLLion ECU;
(6)
(7)
0JNoC
0JNoC
7, 29.1 .1974,
7, 29.1 .1974,
p. 6
p.2
,,
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l'Jhereas in its conclusions of 20 Decenrber 1979, the CounciL invited the
Commission to submit proposals aimed at the ration;rLization of structures
for the preparation, examination and impLementation of Community research
and deveLopment programmes; wheneas a grouping of concerted actions in the
fieLd of medicaL and pubLic heaLth research wouLd constitute a finst con-
tribution towards meeting these objectives;
blhereas the Community is empot^tered to concLude Agreements with non-Member
States in the fieLds covered by this Decision; whereas it may pnove advi-
sabLe to associate the non-Member States par"ticipat'ing in European Coope-
ration in the fieLd of Scientific and TechnicaL Research (C0ST) whoLLy or
partLy w'ith the programme covered by this Decision, in accordance with the
concLusions approved by the CounciL on 18 Juty 1978 in connection w'ith
such cooperation; whereas, on the one lrand, procedur,aL conditions shouLd
be determ'ined so as to lead to a rap'id concLus'ion of such Agreements, and
on the other hand, negot'iations shouLd be opened witlr the non-Member States,
as soon as this Decision is adopted;
[,'lhereas the Cournci L has concLuded such Agreement betl,leen the EEC and the
Swi ss Conf ederat'ion on a concerted pro j ect (8) ;
tJhereas the Scientific and Techn'icaL Research Committee (CREST) has qiven
its opinion on the Comm'ission proposaL;
HAS DECIDED AS F0LL0t'ls
Art i c Le
A concerted research and deveLopment prograrnr'ire of the European Eco:icnii c
Community'in the fieLd of nreCical and pubL'ic heaLth research is hereby
adopted for a perr'od of f ive years commenci'ng on 1 January 198?.
I
( 9.) OJ No L 113, 25,4.1981 , p. 44
t
The prognamme shaL L consi st
research areas described in
the research programmes of
in coordinat'ion at Commun'ity
Annex 1, of those activities
the Member States.
LeveL, with'in the
which form part of
-*l 
"
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ArticLe
The Commission shatt be responsibLe for such coordination.
ArticLe
The appropriations necessary to finance the Community contribution to the
coordinat'ion, the amount of whi ch is estimated at 20 mi LLion ECU, incLud'ing
the expenditure relating to a staff of ten officiaLs, shaLL be entered in
the budget of the European Communities. These figures are given mereLy by
way of indi cation.
The inciicative internaL distribution of funds is shown'in Annex 2.
In the light of experience gained during the impLementation of the programme,
and onovided the oo'inion of the Scientific and TechnicaI Research Committee
(CREST) and of the committee referred to in ArticLe 5 a) is secured beforehand,
the Commission is authorized to transfer funds from one to anothen subpro-
granne, provided that such transfers do not resuLt in an increase or a re-
duct'ion of more than 10 % in the original appropriation for each subprogramme
envi saqed.
ArticLe
The programme shaLL be neexamined at the end of the third yeari this reexami-
nat'ion may lead to a revision of the programme in the course of the fourth
year foltowing the appropriate procedunes, and after the Committee neferred
to in ArticLe 5 a) has- been consuLted. The European ParLiament shaLL be in-
formed of the resuLts of the reexamination.
ArticLe
To faci Litate the execution of the programme,
a) one GeneraL Concerted Action Committee, hereinafter referred to as the
GeneraL Committee, and
,
b)
nr?.,
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f our Concerted Act'ion Commi ttees
management tasks,
assistinq the GeneraL Committee'in'its
shaLl be estabLished.
The terms of reference and the comoosition of these Committees are defined
in Annex 3.
The Commission shaLL be ass'isted in its coordinating action by project Leaders;
appointed by the Commission, after hav'ing consuLted the GeneraL Cornmittee.
Each Committee shaLL draw up its ruLes of internaL procedure. Its secretariat
shaL L be prov'ided by the Commission.
ImpLementation and coordination of the nationaL contribution to the programme
shaLL be carried out by the bodies Listed in Annex A.
ArticLe 6
In accord,ance with a procedure to be Laid down by the Commiss'ion after hav'ing con-
suLted the GeneraLCommittee referred to in ArticLe 5 a), the participating
Member States and the Commission shaLt reguLarLy exchange alL usefuL informa-
tion concerning the execution of the research covered by such activities- |
The participating Member States shaLL provide the Commission with aLL infor-
mation reLevant for coordination purposes. They shaL{. aLso endeavour to pro-'
vide the Commission with information on similar nesearch oLanned or carried
out by bodies wh'ich are not under their authority. Any information shaLL be
treated as confidential if so requested by the Member State which provides it.
At the compLetion of the prognamme, the Commission, in agreement with the
GeneraL Committee, shaLL send to the Member States and the European ParLiament
a summary report on the impLementation and resuLts of the programme particu-
LarLy so that the resuLts obta'ined may be accessibLe as compLeteLy and rapidLy
as possible to the enterprises, institutions and other parties particuLarLy
concerned at the sociaL LeveL. The Commission shalL purbLish this neport six
months after the Latter has been sent to the Member States, unLess a Member
State objects. In the Latter case, the report shaLL be distributed onLy to
those institutions and enterprises that.request it and whose research or pro-
duction activities just'ify access to the resuLts of research alising from the
programme. The Comrn'ission shaL L make the necess ary arrangements for" the report
to remain confidentiaL and not to be divuLged to third parties.
I
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Arti cLe 7
1. In accordance with Article 228 of the Treaty, the Community may conclude
Agreements with the non-Member States participating in European Cooperation
in the fieLd of Scientific and TechnicaL Research (COST) with a view to asso-
ciating them whoLLy or pantLy with this programme.
2. The Commission is hereby authorized to negot'iate the Agreements referred
to 'in paragraph 'l .
ArticLe 8
Decisi.n 8O/344/EEC 'is hereby repeaLed with effect on 1 January 1982.
Done at
For the Counci L
The President
,
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Annex 1
SC]ENTIFIC AND TECHNICAL CONTENT
(Concerted Action Prooramme)
The a'im of this concented European coLLaborat'ion in the sector of medicaL and
oubLic heaLth nesearch is:
- to increase the efficiency of reLevant R & D efforts in the Member States
through the mobiLization of the avaiLabLe nesearch potentiaL of parts of
nationaL programmes and its graduaL coordination at Community LeveL;
- to improve the scientific and technicaL knowLedge in the R & D areas,
seLected for thei limportance to a L L Member^ States tak'ing a part i cuLar
account of potentiaL economic and industriaL deveLopment within the
projects forming them, and
- to provide for the cont'inuation of the 3 concerted projects of the first
medicaL research programme (1978-1981), the integration of the'4 ones of
the second programme (1980-1984) as t^leLL as for new projects of common
interest.
SUB.PROGRAMME I : HEALTHPROBLEMS
Ee:eecg!-stse--1. : Ers:e-p9rt:_s!d_s9:Uq!q!_gcre
- Continuation of the ongoing project reLating to perinataL monitoring (1),
with emphasis on technological deveLopment and assessment of devi ces and
procedures for non-invasive monitoring, and extens'ion to prevention of
mother's ciistress and risk as weI L as of foetaL Loss.
- Impnovement of techniques needed for (partiaLLy) automated chromosome anaLys;is
as weLL as biochemicaL and geneticaL studies to increase possibiLities of its
app L'i cat 'ion .
- Screening of inborn metaboL'ic diseases/ incLuding cystic fibr"osis, hemo-
gLobinopathies and hyperLipoproteinaemi a, by standardization olimprovement
of existing methodologies and developing nell ones/ a:i t,,/eL L as studies on earLy
detection and treatment.
- Continuation of the project reLating to the registration of congenitaL abnor-(2)maLities with extension to improvement of intrauterine diagnos'is and stud'ies
on earLy foetaL Loss, death in earLy chiLdhood and foetaL growth disturbances.
(1) for pnogramme description see: O.J. Np t78r?5"3.80, p.24.(2) rf rr il 
'r : 0.J. No.L5?r23"2,78, p.20.
I
I
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Examinat'ion of curnent practi ces regard'ing care deL'ivery systems, and in
part'icuLar the application of techni caL devi ces and procedures to perinataL
medi cine, incLuding cost/effectiveness evaLuations.
Research area 2 : Sgsrrg.-9i.eqq!eq-snd-!eld:sapp sg
- Cont'inuation of the project reLating to ceLLuLar ageing (2) with extension
of its'immunoLogicaL subproject to the understanding of arthritic diseases
and of its subproject concerning organs to studies of the brain and seniLe
dement'ia .
- continuation of the project reLating to hearing'impairment (1) and of the
subproject on ageing of the crystaLLine Lens of the forego'ing proju.t (2);
deveLopment of adequate aids for visuaL and aud'itory sensoriaL impairment
including b'iomateriaL compat ibi Lity studies.
- Continuation of the ongoing pr"oject r"eLating to the detection of tendency
to thrombosis (1 ) with extension to popuLation studies foLlowing deveLopment
of sui tabLe methodoLogy.
EvaLuat'ion of seLected aids for the disabLed, identification of specific
needs and thei r technoLoqi caL deveLopment.
Examination of care oattern for the chronic oatient with severaL functionaL
disabi L'ities and for the impa'ired eLderLy incLuding epidemioLogicaL aspects.
Research area grse!dsrl-t !-sdeP!e!le!
EvaLuation, improvement, standardization and/or development of quantitative
measurements of hormonaL, psychologicaL and socioLog'ical parameters involved
i n t he adapt'ive process .
Investigation of performance Cecrement in workers under various envi ronmentaL
conditions using the above mentioned methodoLogy.
Comparative studies, thr^ough monitoring the reLevant phys'ioLogicaL variabLes,
in seLected groups suffeling from cardiovascuLar symptoms with parti cuLar re-
fenence to hypertension and ischaemi c heart diseases.
Comparative studies/ through determination of the reLevant psychobioLogicaL and
psychosoc'iaL parameters, in selected groups suffering from gastro-intestinaL
d i seases .
lr
t
(1)
(2)
0.J. No L 78, 25.3.80, p. 24.
0. J . No L 52, 23.2.78, P. 24.
I for prograrrtme descript ion see :
.4[
-?w'/ - 9 -
- AioLogicaL and epidemioLogical studies in workers on the effects of aLcohoL
abuse and the mechanisms involved in the proneness to it, of tobacco on pro-
ducts associated with its consumption, as weLL as of potentiaL op'iate'intal<er
on the centraL nervous system and the generaL metabolism.
SUB.PROGRAMME II : HEALTH RESOURCES
Esseecg!-sr9e---1 : !9s!!!-s9ryte9s-tsgssteb
- Assessment of the present state of the art of heaLth s.ervices nesearch in
the Member States foLIowing deveLopment of a common methodoLogy for compa-
rative evaLuation, and eLaboration of joint projects.
- DeveLopment of heaLth indicators and subsequent assessment of the health
status of the working popuLation in the Commun'ity.
- Studies of heaLth risk factors, infLuence of the working environment on
heaLth, as weLL as the use of medicaL services, sick Leave, accidents at
work and drug consumption; evaLuation of reLevant nationaL activit'ies and
eLaborat'ion of a concerted approach towards orevention.
- Assessment of the feasibitity, by considering'in panticuLar reLevant techno-
Log'icaL progress, and potentiaL importance of community care to the popuLa-
tion'in its home and occupationaL environment, in comparison with hospita-
lization.
Eeseers!-erss--a : !se!!!-Iss!ns!egy
- Continuation of the project reLating to extracorporeaL oxygenat'ion(2) w'ith
extension to advanced technoLogical deveLopments for the repLacement of
further body functions including research on biomateriaLs.
- Continuation of the ongo'ing project reLat'ing to common standards in quanti-
tative eLectrocardiog.uphy (1) with extension to standard'ization and'im-
provement of diagnostic criteria; the same approach wiLL be used for com-
puterized anaLys'is of other" diagnosti c f unctionaL parameters,
- In vivo et in vitro deveLopment of imaging techn'iques foLLowins piLot studies
to define common muLtipurpose packages for appLication.
- DeveLopment of devices and procedures for ambuLatory monitoring of phys'ioLo-
gicaL variabLes of great diagnostic importance to rehabilitation, therapeut'ic
needs, drug use and occupationaL heaLth.
(1) for programme description see : 0.J. No L 78,25.3.80, P.24
Q) for programme description see : 0.J. No t 52, 23.2-78, P. ?8.
a
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CLinicaL and techn'icaL evaluation of new medicaL devices and procedures,
'incLuding cost/efficiency aspects, through coordination of existing faci-
Lities for both comparat ive techni cal testing and user triaLs, considening
'in particuLar: uLtrasonic tissue characterization, acceLerated bone frac-
ture heaL'ing, bLood fLow measurements, automated ceLL'ident'ification and
med'icaL teLemetry.
Research anea 3 : Human Resources
- MethodoLogicaL reseanch on ways and means for providing'industry as weLL
as pubLic and private institutes with highLy quaLified nesearch sc'ientists
in need-areas such as toxi coLogy, occupat ionaL heaLth, advanced heaLth
technoLogy, cLinicaL investigation, heaLth servi ces management and epide-
mioLogy.
- EvaLuation of present and future needs, confrontation of nationaL measures
taken and identification of suitabLe upgrading faci Lities; subsequentLy
deveLopment of coord'inated procedures and assessment of their efficiency
through test cases in toxicoLogy, advanced heaLth technology and cLinicaI
I investiqation.
SUB.PROGRAMME I]I PERSONAL ENVlRONMENT
(Diet and Drugs)
Research area 1 : Nutrition
- DeveLopment and improvement of specific methodoLog'ies for the study of
food and the detection of individuaL predisposit ion to arteriaL hyperten-
sion and digestive tract diseases; bioLogicaL and/or epidemioLog'icaL
studies on their" prevaLence and on the envi ronmentaL f actot"s invoLved, as
weL L as on preventive measures.
Research area 2 : Pha rmaceut i ca L s
- ControlLed post-manketing cLinical triaLs of Large scaLe thnough mob'i Lisa-
tion and coordination of ex'isting faci Lities; appropriate coLLection, sto-
rage and dissemination of information on the efficacy or some specific
effects of seLected oLd and new pharmaceuticaLs.
*)1'
rt
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- DeveLopment of a post-marketing drug surveiLLance project of Large scaLe
through the coordination of existing faci L'ities in the Member States;
coLLection, storage and ear"Ly dissemination of inf<lrmation on adverrse
drug effects of Low jncidence or Late occurrence, jncLuding case controL
survei I Lance and record li nkage drug surve i I Lance.
Annex 2
]NDICATIVE- INTERNAL DISTRIBUTION OF FUNDS
(982 
- 1986)
1
{
Subp rog ramme I :
Subprogramme II :
Subprograrnme III :
45%
40%
1q "/
t
I
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Annex 3
ImpLementation and coordination of the nationaL contributions to_the 
_pjegramme.
The f oL Lowing authorities of the part'ic'ipating Member States wi L I endeavour to
€nsure the imoLementation of the nat'ionaL contributions to the research areas
of the three subprognammes indicated in Annex 1, as weLL as their coordination
at nationaL LeveL :
l
BeLgium
Denma r k
F rance
Ge rmany
Greece
IneLand
ItaLy
Luxembourg
NetherLands
United Kingdom
FRSM - Fonds de La recherche scient'ifique m6dicaLe,
Bruxe L Les
FGt^lO - Fonds voor Geneeskundig tnietenschappeLijk
Onderzoek, BrusseL
Statens LaegevidenskabeL ige Forskningsrad, Kdbenhavn
INSERM - Institut nationaL de La sant6 et de La
recherche m6di caLe, Paris
Bundesminister fur Forschung und TechnoLog'ie, Bonn
Bundesmini ster fUr Jugend, Fam'i Li e und Gesundheit,
Bonn
Bundesministen fUr Arbeit und Soz'iaLordnung, Bonn
Ipiresia Ep'istjmon'ikis Erevn'is ke TechnoLoghias,
At hens
Simvoulion Iatrikon Erevnon, Athens
Medi caL Research Counci L of Ireland, DubLin
Med'ico-SociaL Research Board, DubLin
CNR - ConsigL'io nazionaLe deILa ri cerca' Roma and
Istituto superiore di sanitd, Roma
Ministdne de La santti, Luxembourg
Hoofdgroep Gezondheidsonderzoek TN0, Den Haag
MRC - MedicaL Research CounciL, London and
DHSS - Department of HeaLth and SociaL Security,
London
a
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Annex 4
TERMS OF REFERENCE AND COMPOSIT]ON OF THE COMMITTEE
I. GenenaL Concerted Action Commi ttee
1 . The GeneraL Commi ttee shaL [ :
- contribute to the best possibLe'impLementation of the prognanrme by
giving its opinion to aLL of its aspectsl
- endeavour to integrate those pants of nationaL reseanch activi ties
covered by this programme into a process of coordination at Community
LeveL;
- w'ithin the programme as defined in Annex 1 of the present Decision,
coor.dinate the activation, dunation and possibt.y earLy termination of
the projects forming the research areas of th'is pnogramme, acc;ord'ing
to emerging needs or resuLts of periodicaL evatuations;
- indicate guideLines to the Concerted Action Conrm'ittees;
- advise the Commission on the aLLocation of funds for coordination
purposes, supporting centraL'i zed f aci Lit'i es, meet'i ng urgent needs
in criticaL areas, and undertak'ing epLoratory activities in v'iew
of the pr"eparation of future programmes.
2. The GenenaL Comrnittee's reports and op'inions shaL L be f orwarded to the
Comm'ission and to the Member States parti c'ipating in the programme.
The Commission shaL L forward these opinions to CREST.
3'. The GeneraL Committee shaLL be composed of representatives of the Member
States responsibLe for science and technoLogy in the fieLd of medicaL anrj
pubLic heaLth research and, in part'icuLar, for coordinating the nationaL
contribut'ions to the programme.
II. Concerted Action Commi ttee
1 . Each Committee shaL L :
- assist the GeneraL Committee in its management tasks by ensuring the
scientific and technicaL execut'ion of aLL those projects alLocated to
it'in accordance w'ith'its competence;
I
!
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- evaLuate the resuLts and draw concLusions as negards their appLication;
- be responsibLe for the exchange of information referred to in the first
panagraph of arti cLe 6;
- keep abreast of nationaL research being done in the field of the projects,
and mone especiaLLy of scientifi c and techn'i caL deveLopment likeLy to
af f ect thei n execut'ion;
- suggest guideLines to the project Leaders.
2. The Committeers reports and op'inions shall be forwarded to the General
Committee and to the Commission.
3. The Committee shaLL be composed of experts nominated by the competent
authorities of the Member States and the project Leaders.
I
*
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FINANCIAL RECOND
1. REI,EVA}fI BUDGET HEADJIIG
2. TITLE 0F THE BUDGEIIARY I{EADING: Sectoral n&D programne in the f,ie1d
of Me{ical and Public HeaLth Research 
- 
Concerted Aotion
3. IEOAL SASIS:
rmprementation of Article 235 of the Treaty establishing the EEc
Decision of the Council of ...,.... o.......
4. DESCRIPI.ION, OBJECIIVE A}F JTTSTIFICATION OF THE PROCRA]@:
4.1. Description
The present proposal deals with a new sectoral. research and
d.evelopment prograarme of the ffic in the fierd. of med.ical andpublic health research, to be oanied. out by neans of the
concerted aotion method..
It is subd.ivided. into three subpr,ogrammes:
- 
Subprogramrne l.: Health problems
- 
Subprogramrne 2: Health resources
- 
Subprogramme 3: Personal environment (Ai.et and. dlrgs).
Fach subprog"arrune is further d.etail"ed in researctL areas gu.ouping
several projects.
4.2. _0b.'iectille
It aims at increasing the efficienoy of the relevant R&D effortsin the Member States through the mobilization of the availabLe
research potential of parts of national programmes and its gradual
coordination at Community 1evel.
4.3. Justification
This proposal constitutes a step towards the sectoral grouping of
Comnunity researoh actions in med:leal and. public health research
and. toward.s the rationalization of structures and procedures for the
irnplementation of Conmunity R&D plo€Famnes.
The programme proposal, by presenting a coherent scherne of Comnunity
concerted" research, provid.es for the continuation of the first medical
research progranme (tglg 
- 
19BL) and. the integration of the second
one (t9BO 
- 
1984) as vlel1 as for new activities in critical areas of
common interest.
{
I
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) 5. flINANcTAL rltrtrcATrors rN REspErr oF TlltERIE{TroN AppRopRrATroNs) (including e:rpenditure on staff and adninistrative and. technical
e:cpenditure )
i 5.1. 
-Tot-al-cost for the e:gpected : 320 Mio ECU
5.2. Proportion financed. from:
20 Mio ECU*
r :::;'ff-TJ"-::u*"* 3oo Mio ECU
5.3. Multi".annual timetable
5.3.1. {ngrgrgiations-for-oommitnent (in uio ncU)
Tlpe of
expenditure rg92 1983 1984 T9B5 Lg96 TOTAL
Staff
Administration
Contracts
O.54
a.25
2.O
0.51
0.32
4.0
o,66
a.26
5.0
o.72
o.29
3.3
o.77
o.27
1.0
3.3
l-14
15.3
MTYTI A TI VI4! 2.8 4.93 5.92 4.31 2.A4 20.0lr
t 5.3.2. $rgrgrgigtlo3s-fgr;rgryegt- (in utio UCU)
*q7'
t
5.4. Method. of calcuLation
5.4.I Staff expend.iture
Recruirements have been caLculatect on the basis of a staff complenent
-EB
of lOE persons (includ.ing the staff conplenent of 2 category A
and 2 category C officials allocated" to the 2nd. medical research
progranme), i.€. !
p Slnce Declsion \O/3$/ffifr wiLl be repea1ed with effect from L January^L982,
the amounts which are authorized. under the relevant heading ln the l9B0 and'
L981 budeet and" whieh, as at 1- January I982t have not yet been connitted' or
have been comnitbcl but not yet paid may be used for the execution of the
present progranme.
1gE For l!82, the staff oorplenent requested in the bud.get ls as followsl{ categorJt Ar I category Br 3 category C.
Tyge of
expend:iture 1982 1gB3 1984 1985 1986 r987 TOTAL
Staff
Administration
Contracts
o.54
o.26
1.O
0.61
0.32
3.o
o.65
o.26
4.5
o.72
o.29
4.2
o.77
o.27
2.L
3.3
L.4
15.J
TOTAL 1.8 3.93 5.42 5.2r 3.14 0.5 20. olE
-44'
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-lcategoryAofflcials
-1category3official
- { oategory C officials.
Apart fron the actual staff complement, the calculations also take
account of the rates of salary increases of Cornnission staff used.
to estimate the appropriations entered in the 1t82 budget; the
estimated overalL increases for subsequent years are based on the
rate of change in the general Conmunity price ind.ex used in drawing
up the triennial estinates; i.e. 8r5 % per annurno
5, 4 . 2 . {agi gi gt gali ge _aga/o5 !e Ehgi gal gxge gait glg
This expenditure specifically covers the cost of the organization
of rneeting's (5 coramittees of 30 
- {0 merobers meeting 4 times 2 days),
conrpcation of errperts and. that of missions. ft has been estimated.
on the basis of average requirements.
5,4.3. bcpend.iture on-contrgcls_
This e:cpen&iture covers the financial contribution of the Community
to the coor&ination essential-Iy canied. out r:nder contracts to be
concluded with the project leaders (for organization ofl meetings
of teohnical steering couunittee, seminars, workshops, exchange of
personnelr.d.isseminations of information, scientific and. administrative
helpr etc.), with institutes ensuring oostly centralized. services to
all Member States (for computer including progtamming, production of
exchange of material, breed-:ing and maintainance of oertain animals,
data evaluation of clinical trials, preparatirrn of reference soft-
wanet etc.), with national e:cperts (for eqploratory activities in
forn of stud.ies, etc.) and wlth national or private institutes(for rapid. intervention in the case of an unetcpected. but lrgent
need. etc.).
6. FINA$CIAII IMPLICATIoNS I+I RESPECT 
_0F 4PPROPRIATIONS FOR STAFF ANp
C1JRRENT A}MINISTRATIVE EPFIIDITURE:
(see point J above)
7. IINANCING_ 0F, H(PEIVDITURI
Appropriations to be entered. rrnd"er futr:re bud.gets
B. ,rwltcrr4olls nr nnspncg gr nsuEr'nrg
- 
Community taxes on officialsr salaries
- 
0fficialst contribution to the pension scheme.
9.
- 
Adrninistrative checks by the DG for Financial Control with regard
to the implementation of the budget and. to ensure that the
ocpend:iture has been insumed in a regular and prope? mannerplus checks carried. out by the Contracts Service of DG XII.
- 
Scientific checks: General Concerted. Action Comrnittee assisted. by
4 Concerted. Action Cornrnittees.
{
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